HEADER HYDROLASE/ANTIBIOTIC 03-FEB-21 7LLH TITLE KPC-2 F72Y MUTANT WITH ACYLATED IMIPENEM COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC-1; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: BLA, KPC, KPC1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KPC, CARBAPENEMASE, BETA-LACTAMASE, HYDROLASE, ANTIBIOTIC RESISTANCE, KEYWDS 2 ENZYME, BETA-LACTAM, ANTIBIOTICS, HYDROLASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.FUREY,T.PALZKILL,B.SANKARAN,L.HU,B.V.V.PRASAD REVDAT 5 18-OCT-23 7LLH 1 REMARK REVDAT 4 21-JUL-21 7LLH 1 JRNL REVDAT 3 30-JUN-21 7LLH 1 AUTHOR REVDAT 2 02-JUN-21 7LLH 1 JRNL REVDAT 1 26-MAY-21 7LLH 0 JRNL AUTH I.M.FUREY,S.C.MEHTA,B.SANKARAN,L.HU,B.V.V.PRASAD,T.PALZKILL JRNL TITL LOCAL INTERACTIONS WITH THE GLU166 BASE AND THE CONFORMATION JRNL TITL 2 OF AN ACTIVE SITE LOOP PLAY KEY ROLES IN CARBAPENEM JRNL TITL 3 HYDROLYSIS BY THE KPC-2 BETA-LACTAMASE. JRNL REF J.BIOL.CHEM. V. 296 00799 2021 JRNL REFN ESSN 1083-351X JRNL PMID 34022225 JRNL DOI 10.1016/J.JBC.2021.100799 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.M.PAPP-WALLACE,N.Q.NGUYEN,M.R.JACOBS,C.R.BETHEL, REMARK 1 AUTH 2 M.D.BARNES,V.KUMAR,S.BAJAKSOUZIAN,S.D.RUDIN,P.N.RATHER, REMARK 1 AUTH 3 S.BHAVSAR,T.RAVIKUMAR,P.K.DESHPANDE,V.PATIL,R.YEOLE, REMARK 1 AUTH 4 S.S.BHAGWAT,M.V.PATEL,F.VAN DEN AKKER,R.A.BONOMO REMARK 1 TITL STRATEGIC APPROACHES TO OVERCOME RESISTANCE AGAINST REMARK 1 TITL 2 GRAM-NEGATIVE PATHOGENS USING BETA-LACTAMASE INHIBITORS AND REMARK 1 TITL 3 BETA-LACTAM ENHANCERS: ACTIVITY OF THREE NOVEL REMARK 1 TITL 4 DIAZABICYCLOOCTANES WCK 5153, ZIDEBACTAM (WCK 5107), AND WCK REMARK 1 TITL 5 4234. REMARK 1 REF J MED CHEM V. 61 4067 2018 REMARK 1 REFN ISSN 1520-4804 REMARK 1 PMID 29627985 REMARK 1 DOI 10.1021/ACS.JMEDCHEM.8B00091 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 23691 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1216 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9900 - 4.3700 0.98 2437 192 0.1521 0.1852 REMARK 3 2 4.3700 - 3.4700 0.99 2519 123 0.1578 0.1717 REMARK 3 3 3.4700 - 3.0300 0.99 2560 129 0.1984 0.2598 REMARK 3 4 3.0300 - 2.7500 0.98 2536 97 0.2212 0.2886 REMARK 3 5 2.7500 - 2.5600 0.98 2491 141 0.1995 0.2842 REMARK 3 6 2.5600 - 2.4000 0.97 2492 142 0.1982 0.2253 REMARK 3 7 2.4000 - 2.2800 0.98 2434 151 0.2071 0.2369 REMARK 3 8 2.2800 - 2.1900 0.97 2497 121 0.2003 0.2902 REMARK 3 9 2.1900 - 2.1000 0.97 2509 120 0.2028 0.2464 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.197 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4012 REMARK 3 ANGLE : 0.830 5464 REMARK 3 CHIRALITY : 0.051 620 REMARK 3 PLANARITY : 0.005 710 REMARK 3 DIHEDRAL : 12.849 2382 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 1.1478 -6.1849 9.3881 REMARK 3 T TENSOR REMARK 3 T11: 0.1019 T22: 0.1594 REMARK 3 T33: 0.1750 T12: -0.0009 REMARK 3 T13: -0.0470 T23: -0.0451 REMARK 3 L TENSOR REMARK 3 L11: 0.8593 L22: 2.1511 REMARK 3 L33: 1.5806 L12: 0.0314 REMARK 3 L13: -0.4981 L23: -0.5753 REMARK 3 S TENSOR REMARK 3 S11: 0.0052 S12: -0.0440 S13: 0.0419 REMARK 3 S21: 0.0289 S22: 0.0718 S23: 0.0745 REMARK 3 S31: 0.0380 S32: -0.0378 S33: -0.0667 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN 'A' REMARK 3 SELECTION : CHAIN 'B' REMARK 3 ATOM PAIRS NUMBER : NULL REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LLH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000254631. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976484 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : POINTLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 36.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.02966 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.12700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3C5A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 8,000, 0.1M KSCN, 0.1M SODIUM REMARK 280 ACETATE PH:4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -140.84 50.63 REMARK 500 ARG A 220 -117.22 -114.35 REMARK 500 CYS B 69 -138.96 50.98 REMARK 500 ARG B 220 -116.71 -114.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 478 DISTANCE = 6.89 ANGSTROMS REMARK 525 HOH B 451 DISTANCE = 6.66 ANGSTROMS DBREF 7LLH A 29 290 UNP Q9F663 BLKPC_KLEPN 29 288 DBREF 7LLH B 29 290 UNP Q9F663 BLKPC_KLEPN 29 288 SEQADV 7LLH TYR A 72 UNP Q9F663 PHE 71 ENGINEERED MUTATION SEQADV 7LLH TYR B 72 UNP Q9F663 PHE 71 ENGINEERED MUTATION SEQRES 1 A 260 VAL ALA GLU PRO PHE ALA LYS LEU GLU GLN ASP PHE GLY SEQRES 2 A 260 GLY SER ILE GLY VAL TYR ALA MET ASP THR GLY SER GLY SEQRES 3 A 260 ALA THR VAL SER TYR ARG ALA GLU GLU ARG PHE PRO LEU SEQRES 4 A 260 CYS SER SER TYR LYS GLY PHE LEU ALA ALA ALA VAL LEU SEQRES 5 A 260 ALA ARG SER GLN GLN GLN ALA GLY LEU LEU ASP THR PRO SEQRES 6 A 260 ILE ARG TYR GLY LYS ASN ALA LEU VAL PRO TRP SER PRO SEQRES 7 A 260 ILE SER GLU LYS TYR LEU THR THR GLY MET THR VAL ALA SEQRES 8 A 260 GLU LEU SER ALA ALA ALA VAL GLN TYR SER ASP ASN ALA SEQRES 9 A 260 ALA ALA ASN LEU LEU LEU LYS GLU LEU GLY GLY PRO ALA SEQRES 10 A 260 GLY LEU THR ALA PHE MET ARG SER ILE GLY ASP THR THR SEQRES 11 A 260 PHE ARG LEU ASP ARG TRP GLU LEU GLU LEU ASN SER ALA SEQRES 12 A 260 ILE PRO GLY ASP ALA ARG ASP THR SER SER PRO ARG ALA SEQRES 13 A 260 VAL THR GLU SER LEU GLN LYS LEU THR LEU GLY SER ALA SEQRES 14 A 260 LEU ALA ALA PRO GLN ARG GLN GLN PHE VAL ASP TRP LEU SEQRES 15 A 260 LYS GLY ASN THR THR GLY ASN HIS ARG ILE ARG ALA ALA SEQRES 16 A 260 VAL PRO ALA ASP TRP ALA VAL GLY ASP LYS THR GLY THR SEQRES 17 A 260 CYS GLY VAL TYR GLY THR ALA ASN ASP TYR ALA VAL VAL SEQRES 18 A 260 TRP PRO THR GLY ARG ALA PRO ILE VAL LEU ALA VAL TYR SEQRES 19 A 260 THR ARG ALA PRO ASN LYS ASP ASP LYS HIS SER GLU ALA SEQRES 20 A 260 VAL ILE ALA ALA ALA ALA ARG LEU ALA LEU GLU GLY LEU SEQRES 1 B 260 VAL ALA GLU PRO PHE ALA LYS LEU GLU GLN ASP PHE GLY SEQRES 2 B 260 GLY SER ILE GLY VAL TYR ALA MET ASP THR GLY SER GLY SEQRES 3 B 260 ALA THR VAL SER TYR ARG ALA GLU GLU ARG PHE PRO LEU SEQRES 4 B 260 CYS SER SER TYR LYS GLY PHE LEU ALA ALA ALA VAL LEU SEQRES 5 B 260 ALA ARG SER GLN GLN GLN ALA GLY LEU LEU ASP THR PRO SEQRES 6 B 260 ILE ARG TYR GLY LYS ASN ALA LEU VAL PRO TRP SER PRO SEQRES 7 B 260 ILE SER GLU LYS TYR LEU THR THR GLY MET THR VAL ALA SEQRES 8 B 260 GLU LEU SER ALA ALA ALA VAL GLN TYR SER ASP ASN ALA SEQRES 9 B 260 ALA ALA ASN LEU LEU LEU LYS GLU LEU GLY GLY PRO ALA SEQRES 10 B 260 GLY LEU THR ALA PHE MET ARG SER ILE GLY ASP THR THR SEQRES 11 B 260 PHE ARG LEU ASP ARG TRP GLU LEU GLU LEU ASN SER ALA SEQRES 12 B 260 ILE PRO GLY ASP ALA ARG ASP THR SER SER PRO ARG ALA SEQRES 13 B 260 VAL THR GLU SER LEU GLN LYS LEU THR LEU GLY SER ALA SEQRES 14 B 260 LEU ALA ALA PRO GLN ARG GLN GLN PHE VAL ASP TRP LEU SEQRES 15 B 260 LYS GLY ASN THR THR GLY ASN HIS ARG ILE ARG ALA ALA SEQRES 16 B 260 VAL PRO ALA ASP TRP ALA VAL GLY ASP LYS THR GLY THR SEQRES 17 B 260 CYS GLY VAL TYR GLY THR ALA ASN ASP TYR ALA VAL VAL SEQRES 18 B 260 TRP PRO THR GLY ARG ALA PRO ILE VAL LEU ALA VAL TYR SEQRES 19 B 260 THR ARG ALA PRO ASN LYS ASP ASP LYS HIS SER GLU ALA SEQRES 20 B 260 VAL ILE ALA ALA ALA ALA ARG LEU ALA LEU GLU GLY LEU HET IM2 A 301 20 HET IM2 B 301 20 HETNAM IM2 (5R)-5-[(1S,2R)-1-FORMYL-2-HYDROXYPROPYL]-3-[(2-{[(E)- HETNAM 2 IM2 IMINOMETHYL]AMINO}ETHYL)SULFANYL]-4,5-DIHYDRO-1H- HETNAM 3 IM2 PYRROLE-2-CARBOX YLIC ACID HETSYN IM2 IMIPENEM, OPEN FORM; N-FORMIMIDOYL-THIENAMYCINE, OPEN HETSYN 2 IM2 FORM FORMUL 3 IM2 2(C12 H19 N3 O4 S) FORMUL 5 HOH *129(H2 O) HELIX 1 AA1 ALA A 30 GLY A 41 1 12 HELIX 2 AA2 SER A 71 GLN A 87 1 17 HELIX 3 AA3 GLY A 98 LEU A 102 5 5 HELIX 4 AA4 SER A 106 TYR A 112 1 7 HELIX 5 AA5 VAL A 119 SER A 130 1 12 HELIX 6 AA6 ASP A 131 GLY A 143 1 13 HELIX 7 AA7 GLY A 143 ILE A 155 1 13 HELIX 8 AA8 LEU A 167 SER A 171 5 5 HELIX 9 AA9 SER A 182 LEU A 195 1 14 HELIX 10 AB1 ALA A 200 GLY A 213 1 14 HELIX 11 AB2 ARG A 220 VAL A 225 5 6 HELIX 12 AB3 SER A 275 GLU A 288 1 14 HELIX 13 AB4 ALA B 30 GLY B 41 1 12 HELIX 14 AB5 SER B 71 GLN B 87 1 17 HELIX 15 AB6 GLY B 98 LEU B 102 5 5 HELIX 16 AB7 SER B 106 TYR B 112 1 7 HELIX 17 AB8 VAL B 119 SER B 130 1 12 HELIX 18 AB9 ASP B 131 LEU B 142 1 12 HELIX 19 AC1 GLY B 143 ILE B 155 1 13 HELIX 20 AC2 LEU B 167 SER B 171 5 5 HELIX 21 AC3 SER B 182 LEU B 195 1 14 HELIX 22 AC4 ALA B 200 GLY B 213 1 14 HELIX 23 AC5 ARG B 220 VAL B 225 5 6 HELIX 24 AC6 SER B 275 GLU B 288 1 14 SHEET 1 AA1 5 THR A 56 TYR A 60 0 SHEET 2 AA1 5 SER A 43 ASP A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 AA1 5 ILE A 259 ARG A 266 -1 O TYR A 264 N GLY A 45 SHEET 4 AA1 5 ALA A 244 TRP A 251 -1 N VAL A 250 O ILE A 259 SHEET 5 AA1 5 ALA A 230 THR A 237 -1 N GLY A 236 O ASN A 245 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 SER A 181 -1 O SER A 181 N PHE A 66 SHEET 1 AA3 2 PRO A 94 ILE A 95 0 SHEET 2 AA3 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SHEET 1 AA4 5 THR B 56 TYR B 60 0 SHEET 2 AA4 5 SER B 43 ASP B 50 -1 N VAL B 46 O TYR B 60 SHEET 3 AA4 5 ILE B 259 ARG B 266 -1 O TYR B 264 N GLY B 45 SHEET 4 AA4 5 ALA B 244 TRP B 251 -1 N VAL B 250 O ILE B 259 SHEET 5 AA4 5 ALA B 230 THR B 237 -1 N GLY B 236 O ASN B 245 SHEET 1 AA5 2 PHE B 66 PRO B 67 0 SHEET 2 AA5 2 THR B 180 SER B 181 -1 O SER B 181 N PHE B 66 SHEET 1 AA6 2 PRO B 94 ILE B 95 0 SHEET 2 AA6 2 MET B 117 THR B 118 -1 O MET B 117 N ILE B 95 SSBOND 1 CYS A 69 CYS A 238 1555 1555 2.04 SSBOND 2 CYS B 69 CYS B 238 1555 1555 2.04 LINK OG SER A 70 C7 IM2 A 301 1555 1555 1.42 LINK OG SER B 70 C7 IM2 B 301 1555 1555 1.41 CISPEP 1 GLU A 166 LEU A 167 0 6.74 CISPEP 2 GLU B 166 LEU B 167 0 6.26 CRYST1 34.609 37.123 83.655 88.12 88.38 85.48 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028894 -0.002285 -0.000750 0.00000 SCALE2 0.000000 0.027022 -0.000830 0.00000 SCALE3 0.000000 0.000000 0.011964 0.00000